By Lucy Parkinson, Senior Research Manager, LSN
Medical technology represents a major segment of life science investment, with $2.7 billion in venture allocations going into devices and diagnostics in 2014. At LSN, we track over 700 investors who have an interest in development or clinical-stage medical devices. For RESI San Francisco, LSN has gathered a panel of experienced medical device investors to share their expertise and advice with medtech entrepreneurs.
Moderated by David Cassak, Managing Partner, Innovation In Medtech, our panelists are:
- Paul Grand, Managing Director, Research Corporation Technologies
- Randy Scott, Partner, HealthQuest Capital
- Mark Chin, Vice President, Longitude Capital
- Randy Barko, President & CEO, Ximedica
The panel will explore the challenges of raising a financing round in the medical device sector, providing advice for entrepreneurs from early development stages through to commercialization. These investors will explain what makes a device startup stand out, and how they assess the potential risks of a device opportunity. If you’d like to join us at RESI, register now.
Leave a Reply